第 13 回グローバルヘルス政策研究センターセミナー

開催のお知らせ来る 2018 年 2 月 27 日、第 13 回グローバルヘルス政策研究センター(iGHP)セミナーを開催致します。今回は、香港大学公衆衛生大学院のディレクターであられる、Keiji Fukuda 教授をお招きし、AMR（薬剤耐性）やパンデミックインフルエン
ザをはじめとする様々な国際保健課題への取り組みや、ネゴシエーションをする際に直面するリーダーシップや政策に関する課題についてご講演いただきます。また、セミナー後半ではわが国を代表する感染症専門医や疫学専門家をお迎えし、パネルディスカッション形式でこれまでの臨床現場や組織で直面してきた課題への対応事例を発表していただきます。多くの方々のご参加を心よりお待ち申し上げております。

日時2018 年 2 月 27 日（火） 午後 17:00-19:00

会場

国立国際医療研究センター・研修センター棟 1 階 グローバルヘルス政策研究センター

アクセス

http://kyokuhp.ncgm.go.jp/eng/aboutus/access.html

テーマ“How Does Politics Influence Global Health Policy?: AMR andPandemic Influenza”

言語

英語（日本語通訳なし）

参加費無料（軽食付き）・事前登録制

参加定員数80 名程プログラム内容（敬称略）
17:00-17:05

開会の辞 （NCGM グローバルヘルス政策研究センター長渋谷健司）
17:05-17:10

来賓挨拶 （厚生労働省健康局

結核感染症課長三宅邦明）

17:10-18:00

特別講演 （香港大学公衆衛生大学院ディレクター・教授 KeijiFukuda)

18:00-18:45

パネルディスカッション
モデレーター:•

青木 眞（感染症コンサルタント・米国感染症専門医）

パネリスト:•

Keiji Fukuda（香港大学公衆衛生大学院ディレクター・教授）•

谷口 清洲（国立病院機構•

岩田 健太郎（神戸大学医学部附属病院感染症内科三重病院臨床研究部長）
教授・診療科長）•神谷 元（国立感染症研究所感染症疫学センター第一室任研究官）
18:45-18:55

質疑応答

18:55-19:00

閉会の辞（NCGM 国際感染症センター長大曲貴夫)

主登壇者プロフィール：
Keiji Fukuda, MD, MPH

Keiji Fukuda is the Director and a Clinical Professor at The University of Hong Kong
School of Public Health. He previously worked at the World Health Organization(WHO) in several capacities including Assistant Director-General (ADG) and Special
Representative of the Director-General for antimicrobial resistance; ADG for the Health
Security and Environment Cluster; and Director of the Global Influenza Programme.
Before that, he worked at the U.S. Centers for Disease Control and Prevention (CDC) as
the Epidemiology Section Chief, Influenza Branch and as a Medical Epidemiologist in
the Viral Exanthems and Herpesvirus Branch, National Center for Infectious Diseases.
Professor Fukuda has been a global public health leader in many areas including healthsecurity; emerging infectious diseases including seasonal, avian and pandemic
influenza, SARS, MERS and Ebola; antimicrobial resistance; development of thePandemic Influenza Preparedness Framework; implementation of the International
Health Regulations; food safety; and chronic fatigue syndrome. He has considerable
experience in epidemiological research and field investigations, media communications
and international diplomatic negotiations including those held to establish a historicHeads of State level meeting on antimicrobial resistance at the United Nations in 2016.

He has a BA in Biology, an MD; an MPH; was trained in the Epidemic Intelligence
Service at CDC and is certified in internal medicine by the American Board of InternalMedicine.

Makoto Aoki, MD, FACP, FIDSA

Dr. Aoki is a free-lance infectious disease consultant, and also serves as the Adjunct
Professor of Medicine, Tokyo Medical University.
He received his MD degree from Hirosaki University School of Medicine in 1979. Hecompleted internal medicine residency in the University of Kentucky School ofMedicine followed by an infectious disease fellowship in 1992. He is board-certified ininternal medicine and infectious diseases in the United States.
After completion of his fellowship, Dr. Aoki returned to Japan to provide clinicalinfectious diseases practice at the beginning of the HIV epidemic era in Japan. He once
served on advisory committees for AIDS-related medicine with the Ministry of Health,
Labor and Welfare in Japan. He also organized numerous collaborative relationships
between Japan, the United States of America, and other countries to advance HIV careand management in Japan.
Dr. Aoki is also committed to the education and mentoring of young physicians andother healthcare professionals in the field of clinical infectious diseases in general.

In 2013, he was nominated as one of the ten founders of Japanese medicine by Nikkei
Medical Magazine.

Kiyosu Taniguchi, MD, PhD

Dr. Taniguchi is the Director of the Department of Clinical Research, National Mie
Hospital, National Hospital Organization in Mie, Japan.
Dr. Taniguchi graduated from the School of Medicine at National Mie University in
1984, and had been trained and worked as a pediatrician at several hospitals for 15years. Between 1992 and 1995, he engaged in the international collaboration research
project in Noguchi Memorial Institute for Medical Research in Ghana.
In 1996, he joined the National Institute of Infectious Diseases (NIID), Tokyo, Japanand had committed the establishment of Infectious Disease Surveillance Center andengaged in the national infectious disease surveillance system and FETP. In 2000, he
was dispatched to WHO/HQ/CDS/CSR and worked for international infectious disease
surveillance and control program including GOARN and IHR. After coming back toInfectious Disease Surveillance Center, NIID in 2002, he resumed the activities onnational infectious disease surveillance and response and experienced a lot of infectious
disease outbreaks including SARS, pandemic 2009 and so on.
In 2013, he left NIID and started working at current institution, where in addition to theclinical practice as a pediatrician, he continues to work in the research field on vaccine

preventable diseases, surveillance and epidemiology of infectious diseases and various
international research program.

Kentaro Iwata, MD, PhD, MSc, FACP, FIDSA, CTH, CIC

Dr. Kentaro Iwata is Professor of Infectious Diseases Risk Communication at theResearch Center for Urban Safety and Security, Infectious Diseases Therapeutics ofKobe University Graduate School of Medicine. He also serves as the Chief of theDivision of Infectious Diseases as well as the Division of International Healthcare at
Kobe University Hospital in Hyogo, Japan.

Hajime Kamiya, MD, MPH, PhD

Dr. Hajime Kamiya is the Senior Researcher and Medical Officer at the Infectious
Disease Surveillance Center, National Institute of Infectious Diseases in Tokyo, Japan.
Dr. Kamiya is a native of Japan. He graduated Mie University School of Medicine in1999 and trained as a pediatrician at St.Luke’s International Hospital in Tokyo. He wasboard certificated in pediatrics in 2004.
His interest in immunization posted him to a research fellow at University of California
San Diego (UCSD), Department of Pediatrics, with the County of San Diego Health andHuman Services Agency, Immunization Branch (SDIB). Since 2006, he became
graduate student at Rollins School of Public Health, Emory University, Atlanta GA,
where he learned the fundamental of epidemiology.
After graduating from Emory University, he joined National Institute of Infectious
Diseases, Infectious Disease Surveillance Center in Tokyo as a researcher. In 2012, Dr.
Kamiya was accepted as Epidemiology Intelligence Service (EIS) officer at Center for
Diseases Control and Prevention (CDC). He was assigned to Meningitis and Vaccine
Preventable Disease Branch (MVPDB) and experienced outbreak investigation,evidence based policy making, the strategic planning, interventions and evaluation of
the immunization program from a federal government aspect.
Dr. Kamiya returned to his old position in July 2014. Based on his experiences in theUnited States, Dr. Kamiya is directing his training to be a specialist in immunizationfield.

第 13 回グローバルヘルス政策研究センターセミナー

開催報告

February 27, 2018
Report on the iGHP Special Seminar"How Does Politics Influence Global Health Policy?: Antimicrobial Resistance (AMR)
and Pandemic Influenza"
On February 27, 2018, the Disease Control and Prevention Center (DCC) of NCGM andiGHP had the honor to host a special lecture by Professor Keiji Fukuda, Director andClinical Professor at the University of Hong Kong School of Public Health. The lecture
covered a holistic history of infectious disease control as well as Prof. Fukuda’s own
experiences battling various challenging issues at the global policy level. Throughout
his lecture, Prof. Fukuda emphasized some essential requirements for working in thefield of global health policy: 1) understanding relevant contexts; 2) identifying
underlying issues; 3) focusing on mutual interests; 4) the importance of building trustwith partners to achieve common goals.
Prof. Fukuda’s comprehensive and informative lecture was followed by an inspiring
panel discussion among leading Japanese experts who have extensive knowledge andexperiences in clinical practice, research, education, and domestic and international
health policy in the fields of infectious diseases and epidemiology. Their intriguing
discussion topics included, for example, the needs for field epidemiologists in Japan,
the importance of disease surveillance and utilization of quality data, theindispensability of evidence-based and outcome-based policies and AMR management,
as well as the role political initiative has played in making vaccine recommendations inJapan.
This event was well-received by approximately eighty participants from various
academic and professional backgrounds.
Speakers:
Keiji Fukuda, Director and Clinical Professor, School of Public Health, the Universityof Hong Kong
Kuniaki Miyake, Director, Tuberculosis and Infectious Diseases Control Division,
Health Service Bureau, MOHLW, Japan

Norio Ohmagari, Director, Disease Control and Prevention Center, NCGM
Eiji Hinoshita, Director-General, Bureau of International Health Cooperation, NCGM
Panel Discussion
Moderator:
Makoto Aoki, Free-lance infectious disease consultant, Adjunct Professor of Medicine,Tokyo Medical University
Panelists:
Kiyosu Taniguchi, Director, Department of Clinical Research, National Mie Hospital,
National Hospital Organization, Mie, JapanKentaro Iwata, Professor, Kobe University Graduate School of Medicine and Chief,
Division of Infectious Diseases and Division of International Healthcare, Kobe
University Hospital, Hyogo, Japan
Hajime Kamiya, Senior Researcher, Medical Officer, Infectious Disease SurveillanceCenter, National Institute of Infectious Diseases, Tokyo, Japan